| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - May 31, 2012 |
|||||||||
| Q1 FY13 | $1.40 | $1.31 | $2.78B | $2.59B |
NYSE |
||||
|
Ciena Corporation
CIEN
|
Q2 FY12 | $0.04 | $0.01 | $477.62M | $358.20M |
NYSE |
|||
|
Vera Bradley
VRA
|
Q1 FY13 | $0.31 | $0.29 | $117.20M | $109.64M |
NASDAQ |
|||
|
Movado Group
MOV
|
Q1 FY13 | $0.26 | $0.25 | $103.66M | $99.67M |
NYSE |
|||
|
Splunk
SPLK
|
- | -$0.04 | -$0.06 | $43.20M | $49.59M |
NASDAQ |
|||
|
Rocky Mountain Chocolate Factory
RMCF
|
- | $0.17 | - | $9.66M | - |
NASDAQ |
|||
|
KORU Medical Systems
KRMD
|
- | - | - | $1.74M | - |
NASDAQ |
|||
|
Grace Therapeutics
GRCE
|
- | -$9.77 | - | $12.82K | - |
NASDAQ |
|||
|
Atlas Lithium
ATLX
|
- | -$3.90 | - | $2.45K | - |
NASDAQ |
|||
|
Relmada Therapeutics
RLMD
|
- | - | - | $400 | - |
NASDAQ |
|||
